Prostate cancer
Results
Phase 3
This trial looked at a monoclonal antibody called denosumab (AMG 162) to prevent the spread of prostate cancer to the bones.
Recruitment start: 15 June 2006
Recruitment end: 23 July 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Robert Coleman
Amgen
Last reviewed: 25 Jul 2012
CRUK internal database number: 881
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
